Royalty Pharma (RPRX) Asset Utilization Ratio (2020 - 2026)

Royalty Pharma has disclosed Asset Utilization Ratio across 7 years of filings, most recently posting 0.13 for Q2 2026.

• In Q2 2026, Asset Utilization Ratio changed 0.27% year-over-year to 0.13; the TTM figure through Jun 2026 stood at 0.13 (changed 0.27% YoY), while the FY2025 annual figure was 0.13, down 3.93% from the prior year.
• Asset Utilization Ratio came in at 0.13 for Q2 2026 at Royalty Pharma, up from 0.12 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.15 in Q4 2023 to a low of 0.12 in Q4 2025.
• Average Asset Utilization Ratio over 5 years is 0.13, with a median of 0.13 recorded in 2022.
• Year-over-year, Asset Utilization Ratio gained 12.59% in 2023 and decreased 14.54% in 2024.
• Over 5 years, Asset Utilization Ratio stood at 0.13 in 2022, then grew by 12.59% to 0.15 in 2023, then retreated by 14.54% to 0.12 in 2024, then retreated by 2.22% to 0.12 in 2025, then grew by 4.84% to 0.13 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.13 in Q2 2026, 0.12 in Q1 2026, and 0.12 in Q4 2025.